![]() |
JOURNAL TOOLS |
Publishing options |
eTOC |
To subscribe |
Submit an article |
Recommend to your librarian |
ARTICLE TOOLS |
Reprints |
Permissions |
Cite this article as |
Share |


YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
REVIEWS
Minerva Endocrinologica 2015 June;40(2):105-18
Copyright © 2015 EDIZIONI MINERVA MEDICA
language: English
Fertility preservation in cancer survivors
Winkler-Crepaz K. 1, Ayuandari S. 1, 2, Ziehr S. C. 1, 3, Hofer S. 1, Wildt L. 1 ✉
1 Department of Gynecological, Endocrinology and Reproductive Medicine, Innsbruck Medical University, Innsbruck, Austria; 2 Department of Obstetrics and Gynecology, Gadjah Mada University, Yogyakarta, Indonesia; 3 A.R.T. Bogenhausen, Munich, Germany
Due to the increasing number of long-term cancer survivors, physicians of all specialties are confronted with the need to prevent side effects of the applied oncologic treatments. In the field of reproductive medicine fertility preservation has gained importance as most oncologic treatments have detrimental immediate or long-term impacts on male and female fertility. The American Society of Clinical Oncology and the American Society for Reproductive Medicine, as well as the recently founded International Society for Fertility Preservation propose several established and investigational options for fertility preservation. This review aims to summarize currently available techniques for fertility preservation and future perspectives in this field, as well as to provide recommendations for patient follow-up after cancer and during pregnancy.